The China Mail - Formerra to Supply Foster Medical Compounds in Europe

USD -
AED 3.672496
AFN 64.000202
ALL 80.906293
AMD 358.057859
ANG 1.789785
AOA 918.00003
ARS 1550.781701
AUD 1.431854
AWG 1.8025
AZN 1.705836
BAM 1.740036
BBD 2.003559
BDT 123.852313
BGN 1.747831
BHD 0.375489
BIF 2986.971974
BMD 1
BND 1.274158
BOB 12.010284
BRL 5.488702
BSD 0.994627
BTN 94.291535
BWP 13.758962
BYN 2.955771
BYR 19600
BZD 2.000463
CAD 1.396899
CDF 2312.501901
CHF 0.81723
CLF 0.024951
CLP 981.999904
CNY 6.680903
CNH 6.67941
COP 3247.87
CRC 451.369275
CUC 1
CUP 23.871582
CVE 98.090062
CZK 21.67665
DJF 177.122067
DKK 6.654245
DOP 59.93942
DZD 135.789296
EGP 55.342098
ERN 15
ETB 163.249788
EUR 0.890299
FJD 2.24775
FKP 0.745268
GBP 0.743006
GEL 2.598106
GGP 0.745268
GHS 11.593068
GIP 0.745268
GMD 73.999861
GNF 8810.408095
GTQ 7.60417
GYD 208.500872
HKD 7.845765
HNL 26.733444
HRK 6.76901
HTG 130.391459
HUF 324.5335
IDR 18139.8
ILS 3.165515
IMP 0.745268
INR 94.836702
IQD 1507.908268
IRR 1883408.50203
ISK 121.259715
JEP 0.745268
JMD 157.767152
JOD 0.709041
JPY 158.058501
KES 129.940004
KGS 87.449898
KHR 4062.751587
KMF 440.999851
KPW 899.999961
KRW 1340.964993
KWD 0.311199
KYD 0.8289
KZT 450.213523
LAK 22401.124415
LBP 89543.21849
LKR 330.928532
LRD 169.096028
LSL 16.579341
LTL 2.95274
LVL 0.60489
LYD 6.382657
MAD 9.775113
MDL 17.99331
MGA 4515.451812
MKD 54.771175
MMK 2099.52083
MNT 3598.087189
MOP 8.038145
MRU 40.373975
MUR 47.059726
MVR 15.455022
MWK 1724.696212
MXN 18.767501
MYR 4.070804
MZN 63.909942
NAD 16.579341
NGN 1343.380255
NIO 36.606575
NOK 9.264765
NPR 150.864442
NZD 1.78471
OMR 0.384492
PAB 0.994823
PEN 3.447319
PGK 4.462633
PHP 63.460053
PKR 275.144822
PLN 3.92885
PYG 5942.170819
QAR 3.625947
RON 4.755101
RSD 104.748008
RUB 81.67462
RWF 1471.080115
SAR 3.762939
SBD 8.051718
SCR 13.890446
SDG 601.510318
SEK 9.75791
SGD 1.279675
SHP 0.745545
SLE 22.910099
SLL 20969.504398
SOS 568.442122
SRD 37.542004
STD 20697.981008
STN 21.797153
SVC 8.703542
SYP 13001.999685
SZL 16.563773
THB 33.713498
TJS 9.14122
TMT 3.51
TND 2.972103
TOP 2.40776
TRY 50.019603
TTD 6.742932
TWD 32.837496
TZS 2646.995027
UAH 45.412048
UGX 4202.39832
UYU 39.987723
UZS 11861.722948
VES 890.036599
VND 25736
VUV 119.472328
WST 2.779309
XAF 583.99803
XAG 0.019433
XAU 0.000249574164
XCD 2.70255
XCG 1.79257
XDR 0.707052
XOF 583.99803
XPF 106.091876
YER 236.174961
ZAR 16.558398
ZMK 9001.196279
ZMW 20.156742
ZWL 321.999592
SSP 5745.96484
MXV 2.112498
  • RYCEF

    0.4000

    19.71

    +2.03%

  • CMSC

    0.0000

    20.4

    0%

  • BTI

    0.4200

    56.05

    +0.75%

  • BP

    0.2800

    44.43

    +0.63%

  • RBGPF

    1.6000

    67

    +2.39%

  • RIO

    -0.1500

    94.41

    -0.16%

  • AZN

    -0.4300

    166.15

    -0.26%

  • GSK

    0.4600

    49.7

    +0.93%

  • BCE

    -0.4100

    20.56

    -1.99%

  • NGG

    -0.2500

    75.24

    -0.33%

  • VOD

    -0.0400

    16.58

    -0.24%

  • RELX

    -0.4500

    33.07

    -1.36%

  • BCC

    -0.5500

    76.59

    -0.72%

  • CMSD

    -0.0300

    20.27

    -0.15%

  • JRI

    -0.2500

    10.77

    -2.32%

Formerra to Supply Foster Medical Compounds in Europe
Formerra to Supply Foster Medical Compounds in Europe

Formerra to Supply Foster Medical Compounds in Europe

Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.

Text size:

PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.

Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."

With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.

"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."

Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.

Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.

###

Key Details

  • Formerra will distribute Foster® medical compounds in Europe.

  • This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.

About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.

About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.

Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144

SOURCE: Formerra



View the original press release on ACCESS Newswire

O.Yip--ThChM